Submit Deal

CONCERT PHARMACEUTICALS

HQ - Lexington, MA

Summary

Concert Pharmaceuticals, Inc. is a company focused on developing innovative medicines with unique therapeutic properties to address the needs of patients with chronic diseases.

Deals Overview

Total Deals1

Valued Deals1

Total Value£ 346 M

Avg. Deal Size£ 346 M

Market Context

Senior Management

Roger D. Tung
President and CEO
Marc Becker
CFO
Justine Koenigsberg
Communications Director

Sort

mts health partners

HQ - New York, United States

financial advisors (1)

1 Shared Deal

1 For

£ 346 M

Total Value

chestnut corporate finance

financial advisors (1)

1 Shared Deal

1 For

£ 346 M

Total Value

goodwin procter

HQ - Boston

legal advisors (1)

1 Shared Deal

1 For

£ 346 M

Total Value

joele frank

HQ - New York

pr advisors (1)

1 Shared Deal

1 For

£ 346 M

Total Value

moelis & co

HQ - New York

financial advisors (1)

1 Shared Deal

1 Opposite

£ 346 M

Total Value

davis polk & wardwell

HQ - New York

legal advisors (1)

1 Shared Deal

1 Opposite

£ 346 M

Total Value

bathiya legal

legal advisors (1)

1 Shared Deal

1 Opposite

£ 346 M

Total Value

shearman & sterling

HQ - New York

legal advisors (1)

1 Shared Deal

1 Opposite

£ 346 M

Total Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy